Figure S3 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi; Parvez Vora; Chitra Venugopal; Jarrett Adams; Mohini Singh; Amy Hu; Maryna Gorelik; Minomi Subapanditha; Neil Savage; Jiahe Yang; Chirayu Chokshi; Max London; Alexander Gont; David Bobrowski; Natalie Grinshtein; Kevin R. Brown; Naresh K. Murty; Johan Nilvebrant; David Kaplan; Jason Moffat; Sachdev S. Sidhu; Sheila K. Singh

doi:10.1158/0008-5472.22425583

Preprint2023

Figure S3 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi, Parvez Vora, Chitra Venugopal, Jarrett Adams, Mohini Singh, Amy Hu, Maryna Gorelik, Minomi Subapanditha, Neil Savage, Jiahe Yang, Chirayu Chokshi, Max London, Alexander Gont, David Bobrowski, Natalie Grinshtein, Kevin R. Brown, Naresh K. Murty, Johan Nilvebrant, David Kaplan, Jason Moffat, Sachdev S. Sidhu, Sheila K. Singh

Preprint2023

Data from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi, Parvez Vora, Chitra Venugopal, Jarrett Adams, Mohini Singh, Amy Hu, Maryna Gorelik, Minomi Subapanditha, Neil Savage, Jiahe Yang, Chirayu Chokshi, Max London, Alexander Gont, David Bobrowski, Natalie Grinshtein, Kevin R. Brown, Naresh K. Murty, Johan Nilvebrant, David Kaplan, Jason Moffat, Sachdev S. Sidhu, Sheila K. Singh

Preprint2023

Data from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi, Parvez Vora, Chitra Venugopal, Jarrett Adams, Mohini Singh, Amy Hu, Maryna Gorelik, Minomi Subapanditha, Neil Savage, Jiahe Yang, Chirayu Chokshi, Max London, Alexander Gont, David Bobrowski, Natalie Grinshtein, Kevin R. Brown, Naresh K. Murty, Johan Nilvebrant, David Kaplan, Jason Moffat, Sachdev S. Sidhu, Sheila K. Singh

Preprint2023

Figure S6 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi, Parvez Vora, Chitra Venugopal, Jarrett Adams, Mohini Singh, Amy Hu, Maryna Gorelik, Minomi Subapanditha, Neil Savage, Jiahe Yang, Chirayu Chokshi, Max London, Alexander Gont, David Bobrowski, Natalie Grinshtein, Kevin R. Brown, Naresh K. Murty, Johan Nilvebrant, David Kaplan, Jason Moffat, Sachdev S. Sidhu, Sheila K. Singh

Preprint2023

Figure S6 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Maleeha Qazi, Parvez Vora, Chitra Venugopal, Jarrett Adams, Mohini Singh, Amy Hu, Maryna Gorelik, Minomi Subapanditha, Neil Savage, Jiahe Yang, Chirayu Chokshi, Max London, Alexander Gont, David Bobrowski, Natalie Grinshtein, Kevin R. Brown, Naresh K. Murty, Johan Nilvebrant, David Kaplan, Jason Moffat, Sachdev S. Sidhu, Sheila K. Singh

Figure S3 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Abstract

Discussion(0)

Open reviews(0)

Related publications

Figure S3 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Data from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Data from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Figure S6 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma

Figure S6 from Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma